S100-β Determination Kit


S100-β Determination Kit(Fluorescence Immunochromatography Assay) Abbreviation: S100-β


S100-β Determination Kit is an in vitro diagnostic test for the quantitative detection of S100-β in human serum and plasma specimens. 

 With the increase of age, the incidence of stroke increases significantly. Cerebrovascular disease is a serious threat to human health due to its high morbidity, high mortality, and high disability rate. Stroke patients are often accompanied by neurological dysfunctions of varying degrees, such as aphasia, hemiplegia, and mental decline, which seriously affect the quality of life of patients and increase the economic burden on society and families. It is currently one of the most common death reasons of the elderly. Therefore, research on the prevention and treatment of cerebrovascular disease has high clinical application value and broad application prospects and is currently a hot research topic in the international academic community. The relationship between S100-β protein and cerebrovascular disease has become the focus of attention in recent years. The study found that S100-β protein, as a biochemical marker of damage to the new nervous system, is currently considered to be the specific protein that can best reflect the degree and prognosis of brain damage. Therefore, S100-β is used to judge the occurrence, development and prognosis of acute cerebrovascular disease, and provide a theoretical basis for the early diagnosis and treatment of cerebrovascular disease. There are many detection methods for S100-β protein (S100-β), depending on the characteristics of the detected substances and the substances bound to the antigen-antibody complex, the commonly used methods are chemiluminescence immunoassay, colloidal gold assay, and immunochromatography assay. 

S100-β Determination Kit is a rapid, specific, and simple quantitative detection kit established by solid phase immunochromatography technology.